Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Monster Beverage (MNST) Analysts See $0.37 EPS; Medicines Co (MDCO)'s ...


The firm markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention; Ionsys, a fentanyl iontophoretic transdermal system for the short term management of acute postoperative pain for adults requiring opioid analgesia in the hospital.


It also markets Minocin IV, an intravenous formulation of a tetracycline-class antibiotic used for the treatment of infections due to susceptible strains of designated gram-negative bacteria; and Orbactiv, an intravenous antibiotic used for the treatment of adult patients with acute bacterial skin and skin structure infections, or caused or suspected to be caused by susceptible isolates of designated gram-positive microorganisms.


The Monster Energy Drinks segment sells ready-to-drink packaged drinks and non-carbonated dairy based coffee energy drinks primarily to bottlers and full service Beverage distributors, as well as sells directly to retail grocery and specialty chains, wholesalers, club stores, mass merchandisers, convenience chains, food service customers, and the military.


Among 21 analysts covering Monster Beverage Corp ( NASDAQ:MNST ), 16 have Buy rating, 1 Sell and 4 Hold.


Sarissa Capital Management Lp holds 20.03% of its portfolio in The Medicines Company for 1.75 million shares.




READ MORE (Hill Country Times)


  • Monster Beverage Corporation (MNST) Analysts See $0.37 EPSBZ Weekly
  • Monster Beverage (MNST) Lifted to Buy at BidaskClubStockNewsTimes
  • Monster Beverage Corporation (MNST) Stake Cut by Rainier Investment Management LLCBangaloreWeekly
  • FY2018 EPS Estimates for Monster Beverage Co. (NASDAQ:MNST) Raised by AnalystWeek Herald
  • Monster Beverage (NASDAQ:MNST) Stock Rating Reaffirmed by Credit Suisse GroupStockNewsTimes
  • Wealth Enhancement Advisory Services LLC Buys Shares of 32956 Monster Beverage ...StockNewsTimes
  • Monster Beverage Co. (MNST) Shares Bought by National Pension ServiceStockNewsTimes
  • Monster Beverage (MNST) Price Target Raised to $71.00 at BMO Capital MarketsThe Ledger Gazette
  • Monster Beverage (NASDAQ:MNST) Earns Buy Rating from Stifel NicolausStockNewsTimes


This post first appeared on The 5th News, please read the originial post: here

Share the post

Monster Beverage (MNST) Analysts See $0.37 EPS; Medicines Co (MDCO)'s ...

×

Subscribe to The 5th News

Get updates delivered right to your inbox!

Thank you for your subscription

×